Coherus Distances Itself From Biosimilar Interchangeability

US Humira Biosimilars May Feature Designation In 2023

 
• By Dean Rudge
  
Railway tracks with switches and interchanges at a main line in Germany with geometrical structures black and white
A lack of interchangeability has not hindered biosimilar uptake in Europe, Coherus argues • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products